Scholars@Duke
Alexandra Thomas

Alexandra Thomas

Professor of Medicine
Medicine, Medical Oncology
40 Duke Medicine Circle, Clinic 2-2, Durham, NC 27710
ORCID iDhttps://orcid.org/0000-0001-9022-2229
40 Duke Medicine Circle, Clinic 2-2, Durham, NC 27710

Scholarly Works - Conferences

Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.

Conference Journal of Clinical Oncology · August 10, 2024 1 Background: Uncommon histologies are over-represented among high-risk breast cancer (BC) and denote an area with limited trial data and of significant unmet medical need. To better understand trial outcomes in this group and id ... Full text Cite

Abstract PO3-19-04: The CROWN STUDY: A multicenter prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor

Conference Cancer Research · May 2, 2024 AbstractBackground: Treatment for premenopausal women with high or intermediate risk hormone receptor (HR)+ breast cancer (BC) includes the concurrent use of ovarian function suppression (OFS) and an aromata ... Full text Cite

The CROWN study (CaRdiac outcomes with near complete estrogen deprivation): A multicenter, prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor.

Conference Journal of Clinical Oncology · June 1, 2023 TPS12142 Background: Treatment for premenopausal women with high or intermediate risk hormone receptor (HR)+ breast cancer (BC) now includes the concurrent use of ovarian function suppression (OFS) and an aromatase inhibitor (AI) ... Full text Cite

Phase I study of muscadine grape extract in advanced malignancy.

Conference Journal of Clinical Oncology · May 20, 2018 Full text Cite